Obesity in dogs, Part 1: Exploring the causes and consequences of canine obesity - Veterinary Medicine
  • SEARCH:
Medicine Center
DVM Veterinary Medicine Featuring Information from:

ADVERTISEMENT

Obesity in dogs, Part 1: Exploring the causes and consequences of canine obesity
This increasingly common condition decreases a dog's life span, increases its risk for various cancers, and causes orthopedic problems—just to name a few of the possible sequelae.


VETERINARY MEDICINE


41. Bland IM, Guthrie-Jones A, Taylor RD, et al. Dog obesity: owner attitudes and behaviour. Prev Vet Med 2009;92:333-340.

42. Burkholder WJ, Bauer JE. Foods and techniques for managing obesity in companion animals. J Am Vet Med Assoc 1998;212:658-662.

43. Courcier E, Thomson R, Mellor D, et al. Canine obesity: do owners see what you see? in Proceedings. Br Sm Anim Vet Cong, 2009.

44. Vuorela N, Saha MT, Salo MK. Parents underestimate their child's overweight. Acta Paediatr 2010;99:1374-1379.

45. Courcier EA, Thomson RM, Mellor DJ, et al. An epidemiological study of environmental factors associated with canine obesity. J Small Anim Pract 2010;51(7):362-367.

46. Lawler DF, Evans RH, Larson BT, et al. Influence of lifetime food restriction on causes, time, and predictors of death in dogs. J Am Vet Med Assoc 2005;226:225-231.

47. Gayet C, Bailhache E, Dumon H, et al. Insulin resistance and changes in plasma concentration of TNFalpha, IGF1, and NEFA in dogs during weight gain and obesity. J Anim Physiol Anim Nutr (Berl) 2004;88:157-165.

48. Gayet C, Leray V, Saito M, et al. The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-gamma target genes, in dogs. Br J Nutr 2007;98:497-503.

49. Pi-Sunyer X. The metabolic syndrome: how to approach differing definitions. Med Clin North Am 2007;91:1025-1040, vii.

50. Dixon RM, Reid SW, Mooney CT. Epidemiological, clinical, haematological and biochemical characteristics of canine hypothyroidism. Vet Rec 1999;145:481-487.

51. Bensaid M, Gary-Bobo M, Esclangon A, et al. The cannabinoid CBI receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. Mol Pharmacol 2003;63:908-914.

52. Daminet S, Jeusette I, Duchateau L, et al. Evaluation of thyroid function in obese dogs and in dogs undergoing a weight loss protocol. J Vet Med A Physiol Pathol Clin Med 2003;50:213-218.

53. Reusch CE. Hyperadrenocorticism. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine. 6th ed. Philadelphia, Pa: Saunders, 2005;1592-1610.

54. Feldman EC, Nelson RW. Canine and feline endocrinology & reproduction. 3rd ed. Philadelphia, Pa: Saunders, 2004;252-353.

55. Chiu JD, Kolka CM, Richey JM, et al. Experimental hyperlipidemia dramatically reduces access of insulin to canine skeletal muscle. Obesity (Silver Spring) 2009;17:1486-1492.

56. Lauten SD. Nutritional risks to large-breed dogs: from weaning to the geriatric years. Vet Clin North Am Small Anim Pract 2006;36:1345-1359, viii.

57. Huck JL, Biery DN, Lawler DF, et al. A longitudinal study of the influence of lifetime food restriction on development of osteoarthritis in the canine elbow. Vet Surg 2009;38:192-198.

58. Kealy RD, Lawler DF, Ballam JM, et al. Evaluation of the effect of limited food consumption on radiographic evidence of osteoarthritis in dogs. J Am Vet Med Assoc 2000;217:1678-1680.

59. White RAS, Williams, JM. Tracheal collapse in the dog—is there really a role for surgery? A survey of 100 cases. J Small Anim Pract 1994;35(4):191-196.

60. Panciera DL. Conditions associated with canine hypothyroidism. Vet Clin North Am Small Anim Pract 2001;31:935-950.


ADVERTISEMENT

Source: VETERINARY MEDICINE,
Click here